These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 18948169
1. Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma. Siegelin MD, Habel A, Gaiser T. Neurosci Lett; 2008 Dec 19; 448(1):161-5. PubMed ID: 18948169 [Abstract] [Full Text] [Related]
2. TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin. Gaiser T, Becker MR, Habel A, Reuss DE, Ehemann V, Rami A, Siegelin MD. Neurosci Lett; 2008 Sep 12; 442(2):109-13. PubMed ID: 18634847 [Abstract] [Full Text] [Related]
3. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, Yoon AR, Yun CO, Choi KS. Cancer Res; 2007 Sep 01; 67(17):8274-84. PubMed ID: 17804742 [Abstract] [Full Text] [Related]
4. 17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis. Siegelin MD, Habel A, Gaiser T. Neurobiol Dis; 2009 Feb 01; 33(2):243-9. PubMed ID: 19027068 [Abstract] [Full Text] [Related]
5. Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis. Siegelin MD, Siegelin Y, Habel A, Gaiser T. Neurosci Lett; 2009 Apr 03; 453(2):92-7. PubMed ID: 19356600 [Abstract] [Full Text] [Related]
6. Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Kim EH, Kim SU, Choi KS. Oncogene; 2005 Jan 27; 24(5):838-49. PubMed ID: 15531913 [Abstract] [Full Text] [Related]
7. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP. Siegelin MD, Gaiser T, Siegelin Y. Neurochem Int; 2009 Nov 27; 55(6):423-30. PubMed ID: 19409438 [Abstract] [Full Text] [Related]
8. Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2. Siegelin MD, Gaiser T, Habel A, Siegelin Y. Neurosci Lett; 2009 May 01; 454(3):223-8. PubMed ID: 19429088 [Abstract] [Full Text] [Related]
9. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, Mukhtar H. Oncogene; 2008 Mar 27; 27(14):2055-63. PubMed ID: 17998943 [Abstract] [Full Text] [Related]
10. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death. Basu A, Haldar S. Int J Oncol; 2009 Jan 27; 34(1):281-6. PubMed ID: 19082499 [Abstract] [Full Text] [Related]
11. Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2. Siegelin MD, Gaiser T, Habel A, Siegelin Y. Cancer Lett; 2009 Oct 08; 283(2):230-8. PubMed ID: 19398149 [Abstract] [Full Text] [Related]
12. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, Choi KS. Oncogene; 2005 Oct 20; 24(46):6877-89. PubMed ID: 16007142 [Abstract] [Full Text] [Related]
13. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H, Voss V, Seifert V, Prehn JH, Kögel D. FEBS J; 2008 Apr 20; 275(8):1925-36. PubMed ID: 18341587 [Abstract] [Full Text] [Related]
14. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS. Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319 [Abstract] [Full Text] [Related]
15. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY, Kim EH, Park SS, Lim JH, Kwon TK, Choi KS. J Cell Biochem; 2008 Dec 15; 105(6):1386-98. PubMed ID: 18980244 [Abstract] [Full Text] [Related]
16. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, Ishii M, Takashima H, Katagishi T, Kimura H, Minami M, Itoh Y, Kagawa K, Okanoue T. J Hepatol; 2006 Jun 15; 44(6):1074-82. PubMed ID: 16481065 [Abstract] [Full Text] [Related]
17. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression. Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME. Int J Oncol; 2007 Oct 15; 31(4):705-11. PubMed ID: 17786300 [Abstract] [Full Text] [Related]
18. The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate. McLaughlin N, Annabi B, Bouzeghrane M, Temme A, Bahary JP, Moumdjian R, Béliveau R. Brain Res; 2006 Feb 03; 1071(1):1-9. PubMed ID: 16412397 [Abstract] [Full Text] [Related]
19. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T. Mol Cancer Res; 2008 Dec 03; 6(12):1852-60. PubMed ID: 19074830 [Abstract] [Full Text] [Related]
20. Halocynthiaxanthin and peridinin sensitize colon cancer cell lines to tumor necrosis factor-related apoptosis-inducing ligand. Yoshida T, Maoka T, Das SK, Kanazawa K, Horinaka M, Wakada M, Satomi Y, Nishino H, Sakai T. Mol Cancer Res; 2007 Jun 03; 5(6):615-25. PubMed ID: 17579120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]